{"transactions":[{"id":2355725,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":129638,"kind":"person","name":"Davis Derek M","position":1,"cik":"0001399228","reported_name":"Davis Derek M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Controller & CAO"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:05:59.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":1026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."}],"balance_after":1026,"derivative":{"exercise_date":"2024-02-25","expiration_date":"2024-02-25","underlying":"Common Stock","underlying_shares":1026},"source":{"system":"sec-edgar","filing":"0001062993-22-006628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299322006628/form4.xml","form_type":"4"}},{"id":2355724,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":129638,"kind":"person","name":"Davis Derek M","position":1,"cik":"0001399228","reported_name":"Davis Derek M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Controller & CAO"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:05:59.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units (\"PRSUs\") held by Company employees, included the reporting person, were converted into time-based RSUs.  Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level.  The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed."}],"balance_after":661,"derivative":{"exercise_date":"2023-02-21","expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":661},"source":{"system":"sec-edgar","filing":"0001062993-22-006628","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299322006628/form4.xml","form_type":"4"}},{"id":2379194,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":129638,"kind":"person","name":"Davis Derek M","position":1,"cik":"0001399228","reported_name":"Davis Derek M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Controller & CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-23T22:02:05.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":7583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests annually over three years in increments of one-third each year, commencing on February 18, 2023."}],"balance_after":7583,"derivative":{"exercise_price":120.82,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":7583},"source":{"system":"sec-edgar","filing":"0001062993-22-005362","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299322005362/form4.xml","form_type":"4"}},{"id":2444833,"issuer":{"id":3278,"kind":"organization","name":"ZIMMER BIOMET HOLDINGS, INC.","symbol":"ZBH"},"owners":[{"id":129638,"kind":"person","name":"Davis Derek M","position":1,"cik":"0001399228","reported_name":"Davis Derek M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Controller & CAO"}}],"security":"Restricted Stock Units","published_at":"2022-01-05T21:48:55.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock."}],"balance_after":830,"derivative":{"exercise_date":"2023-12-01","expiration_date":"2023-12-01","underlying":"Common Stock","underlying_shares":830},"source":{"system":"sec-edgar","filing":"0001062993-22-000634","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1136869/000106299322000634/form4.xml","form_type":"4"}}]}